A man who took magic mushrooms for a scientific study said it helped him see a basic truth about relationships
silhouette man clouds alone thinking hopeful
silhouette man clouds alone thinking hopeful

(Daiana Lorenz/Youtube)

1990 was a year of life and death for Clark Martin. His daughter was born, and he was diagnosed with cancer.

Over the next 20 years, as his daughter took her first steps, experienced her first day of school, and eventually grew into a smart, fiercely independent teenager, doctors waged a blitzkrieg on Martin's body. Six surgeries. Two experimental treatments. Thousands of doctor visits. The cancer never went into remission, but Martin and his doctors managed to keep it in check by staying vigilant, always catching the disease just as it was on the brink of spreading.

Still, the cancer took its toll. Martin was riddled with the effects of anxiety and depression. He had become so focused on saving his body from the cancer that he hadn't made time for the people and things in his life that really mattered. His relationships were in shambles; he and his daughter barely spoke.

So in 2010, after reading an article in a magazine about a medical trial that involved giving people with cancer and anxiety the drug psilocybin — the active ingredient in the psychedelic drug magic mushrooms — he contacted the people running the experiment and asked to be enrolled.

After weeks of lengthy questionnaires and interviews, he was selected. On a chilly December morning, Martin walked into the facility at Johns Hopkins, where he was greeted by two researchers, including Bill Richards, a psychologist. The three of them sat and talked in the room for half an hour, going over the details of the study and what might happen. Martin was just one participant in a large, five-year study done at Johns Hopkins and New York University which aimed to look at the effect of psilocybin on cancer patients with anxiety and depression. That study's promising results have prompted some researchers to liken the treatment to a "surgical intervention."

The trip

In the homey facility at Johns Hopkins, Martin received a pill, which he swallowed with a glass of water. For study purposes, he couldn't know whether it was a placebo or psilocybin, the drug the researchers aimed to study.

Patient on couch with chairs 4 psychedelic trial shrooms johns hopkins
Patient on couch with chairs 4 psychedelic trial shrooms johns hopkins

(The set-up at Johns Hopkins featuring an anonymous participant (not Martin).Johns Hopkins for Business Insider)

Next, he lay back on the couch, covered his eyes with the soft shades he'd been given, and waited.

Within a few minutes, Martin began to feel a sense of intense panic.

"It was quite anxiety-provoking," he said. "I tried to relax and meditate, but that seemed to make it worse, and I just wanted everything to snap back into place. There was no sense of time, and I realized the drug was in me and there was no stopping it."